Literature DB >> 7679073

Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament.

M Novak1, J Kabat, C M Wischik.   

Abstract

The Alzheimer's disease paired helical filament (PHF), after digestion with Pronase, retains its characteristic morphological features. We term this the protease resistant core PHF. A 12 kDa tau fragment can be released from the core as an essentially pure preparation. Sequence analysis of this fragment revealed six distinct N-termini beginning in the repeat region of tau. The precise C-terminus is unknown, but the fragment is approximately 100 residues long. A monoclonal antibody, mAb 423, which recognizes the core PHF and the 12 kDa tau fragment, does not recognize normal full-length tau. We describe cDNA synthesis and expression of candidate 12 kDa tau analogues which permit the mapping of the mAb 423 epitope. mAb 423 recognizes all and only those analogues which terminate at Glu391, which lies beyond the homology repeat region. Addition or removal of a single residue at the C-terminus abolishes immunoreactivity. Therefore, mAb 423, together with knowledge of the N-terminus, can be used to measure the precise extent of 12 kDa PHF core tau fragment which we term the minimal protease resistant tau unit of the core PHF. This unit is 93-95 residues long, which is equivalent to three repeats, but is 14-16 residues out of phase with respect to the maximum homology organization of the repeat region. mAb 423 labels isolated PHFs prior to Pronase digestion and intracellular granular and neurofibrillary degeneration in Alzheimer's disease tissues. The constraints which determine endogenous truncation at Glu391 appear to be characteristic of an assembled configuration of tau, either within the PHF or its precursor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679073      PMCID: PMC413214          DOI: 10.1002/j.1460-2075.1993.tb05665.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  20 in total

1.  Use of T7 RNA polymerase to direct expression of cloned genes.

Authors:  F W Studier; A H Rosenberg; J J Dunn; J W Dubendorff
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

2.  Characterisation of the first monoclonal antibody against the pronase resistant core of the Alzheimer PHF.

Authors:  M Novak; C M Wischik; P Edwards; R Pannell; C Milstein
Journal:  Prog Clin Biol Res       Date:  1989

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes.

Authors:  P Matsudaira
Journal:  J Biol Chem       Date:  1987-07-25       Impact factor: 5.157

6.  Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease.

Authors:  C M Wischik; M Novak; H C Thøgersen; P C Edwards; M J Runswick; R Jakes; J E Walker; C Milstein; M Roth; A Klug
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

7.  Structural characterization of the core of the paired helical filament of Alzheimer disease.

Authors:  C M Wischik; M Novak; P C Edwards; A Klug; W Tichelaar; R A Crowther
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

8.  The product of the mei3+ gene, expressed under control of the mating-type locus, induces meiosis and sporulation in fission yeast.

Authors:  M McLeod; M Stein; D Beach
Journal:  EMBO J       Date:  1987-03       Impact factor: 11.598

9.  Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.

Authors:  M Goedert; M G Spillantini; M C Potier; J Ulrich; R A Crowther
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

10.  Tau protein binds to microtubules through a flexible array of distributed weak sites.

Authors:  K A Butner; M W Kirschner
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

View more
  115 in total

1.  Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation.

Authors:  L C Serpell; J Berriman; R Jakes; M Goedert; R A Crowther
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  Three- and four-repeat Tau coassemble into heterogeneous filaments: an implication for Alzheimer disease.

Authors:  Ayisha Siddiqua; Martin Margittai
Journal:  J Biol Chem       Date:  2010-10-04       Impact factor: 5.157

3.  Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease.

Authors:  E B Mukaetova-Ladinska; F Garcia-Siera; J Hurt; H J Gertz; J H Xuereb; R Hills; C Brayne; F A Huppert; E S Paykel; M McGee; R Jakes; W G Honer; C R Harrington; C M Wischik
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

4.  Template-assisted filament growth by parallel stacking of tau.

Authors:  Martin Margittai; Ralf Langen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

5.  Tau isoform composition influences rate and extent of filament formation.

Authors:  Qi Zhong; Erin E Congdon; Haikady N Nagaraja; Jeff Kuret
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

6.  Cortical and hippocampal neurons from truncated tau transgenic rat express multiple markers of neurodegeneration.

Authors:  Peter Filipcik; Martin Cente; Gabriela Krajciova; Ivo Vanicky; Michal Novak
Journal:  Cell Mol Neurobiol       Date:  2009-03-05       Impact factor: 5.046

Review 7.  Tau aggregation in Alzheimer's disease: what role for phosphorylation?

Authors:  Guy Lippens; Alain Sillen; Isabelle Landrieu; Laziza Amniai; Nathalie Sibille; Pascale Barbier; Arnaud Leroy; Xavier Hanoulle; Jean-Michel Wieruszeski
Journal:  Prion       Date:  2007-01-23       Impact factor: 3.931

8.  Multiple mechanisms of extracellular tau spreading in a non-transgenic tauopathy model.

Authors:  Meghan N Le; Wonhee Kim; Sangmook Lee; Ann C McKee; Garth F Hall
Journal:  Am J Neurodegener Dis       Date:  2012-11-25

9.  Monitoring pathological assembly of tau and beta-amyloid proteins in Alzheimer's disease.

Authors:  R Mena; P Edwards; O Pérez-Olvera; C M Wischik
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

10.  Memantine prevents sensitivity to excitotoxic cell death of rat cortical neurons expressing human truncated tau protein.

Authors:  Martin Cente; Stanislava Mandakova; Peter Filipcik
Journal:  Cell Mol Neurobiol       Date:  2009-03-17       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.